Swedbank Ab Elanco Animal Health Inc Transaction History

Swedbank Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 09, 2024	SELL	$8.08 - $10.37 $367,680 - $471,886	-45,505 Closed	0 $0
Q1 2023 Dec 09, 2024	SELL	$8.79 - $14.58 $1.74 Million - $2.89 Million	-198,200 Reduced 81.33%	45,505 $427,000
Q3 2022 Dec 09, 2024	SELL	$12.41 - $32.42 $1.85 Million - $4.83 Million	-149,042 Reduced 37.95%	243,705 $3.02 Million
Q2 2022 Dec 09, 2024	BUY	$19.63 - $26.62 $164,361 - $222,889	8,373 Added 2.18%	392,747 $7.71 Million
Q4 2021 Dec 09, 2024	BUY	$27.74 - $34.09 $6,935 - $8,522	250 Added 0.07%	384,374 $10.9 Million
Q3 2021 Dec 09, 2024	BUY	$29.2 - $36.72 $1.03 Million - $1.29 Million	35,211 Added 10.09%	384,124 $12.2 Million
Q2 2021 Dec 09, 2024	BUY	$28.76 - $35.98 $6.66 Million - $8.33 Million	231,411 Added 196.94%	348,913 $12.1 Million
Q1 2021 Dec 09, 2024	BUY	$27.85 - $34.49 $3.27 Million - $4.05 Million	117,502 New	117,502 $3.46 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.72B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.